PEAL Capital Group acquires Derma Med
Private equity firm PEAL Capital Group has acquired the London-based cosmetic training provider Derma Med (Derma Medical) for an undisclosed amount.
This is the first deal for the PEAL Capital Fund ILP. The transaction will see Derma Med further expanding internationally.
Founded in 2017, Derma Med provides non-surgical aesthetic treatment training in London, Birmingham, Manchester, and Edinburgh. The group runs international training academies in Sydney, Brisbane, Melbourne, and Perth in Australia, Stockholm, Sweden and Dubai, UAE.
The firm pointed to the hike of the global facial injectables market which is projected to grow from $4.77 billion in 2021 to $9.07 billion in 2028 at a CAGR of 9.6% in the forecast period 2021-2028, according to Fortune.
It took the input of at least 100 dedicated professionals to close out this deal, PEAL Capital said.
Joining the Derma Med team as executive chair is Jennifer Fox, who has a background in global hospitality, luxury branding, and leading executive teams.
PwC, Silicon Valley Bank, Rosetta Tax, Locke Lord, McCann FitzGerald, Waystone, SEI, Ince, Kroll and RWT Growth advised on this transaction.